Leah Lawrence

Changes to modern treatment protocols for pediatric Hodgkin lymphoma seem to have reduced late cardiotoxicity.

Interval breast cancers and screen-detected breast cancers have distinct genetic profiles, according to researchers.

Updated trial results suggest that lenvatinib and pembrolizumab can provide durable benefits over sunitinib in RCC.

Intensification of ADT prolonged PSA-PFS in patients with biochemically recurrent prostate cancer in a phase 3 trial.

Neoadjuvant trabectedin may be an alternative to standard chemotherapy for patients with high-grade myxoid liposarcoma of the extremities or trunk, according to researchers.

Certain foods are associated with a lower risk of premature aging in adult survivors of childhood cancer, new research suggests.

Researchers have released new guidelines for stereotactic body radiotherapy in patients with primary renal cell carcinoma.

Bevacizumab may improve the efficacy of chemotherapy but increase toxicity when given to pediatric patients with relapsed or refractory, high-risk neuroblastoma.

Diabetes mellitus may contribute to the higher incidence of multiple myeloma seen in Black patients, research suggests.

Patients with advanced melanoma can derive a benefit from BRAF/MEK inhibitor rechallenge, new data suggest.